HomepageASRT • NASDAQ
add
Depomed
Vorige slotkoers
$ 0,84
Dag-range
$ 0,80 - $ 0,84
Jaar-range
$ 0,74 - $ 1,80
Beurswaarde
76,71 mln. USD
Gem. volume
809,48K
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 29,20 mln. | -18,03% |
Bedrijfskosten | 24,40 mln. | -18,13% |
Netto inkomsten | -2,92 mln. | 98,96% |
Netto winstmarge | -10,00 | 98,73% |
Winst per aandeel | 0,03 | 200,00% |
EBITDA | 3,96 mln. | -56,54% |
Effectief belastingtarief | -1,53% | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 88,58 mln. | 15,21% |
Totale activa | 276,00 mln. | -27,37% |
Totale passiva | 145,48 mln. | -22,27% |
Totaal aandelenvermogen | 130,52 mln. | — |
Uitstaande aandelen | 95,48 mln. | — |
Koers-boekwaardeverhouding | 0,61 | — |
Rendement op activa | -2,47% | — |
Rendement op kapitaal | -4,00% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -2,92 mln. | 98,96% |
Operationele kasstroom | -35,00K | -101,36% |
Kasstroom uit beleggingen | -6,71 mln. | -261,90% |
Kasstroom uit financiering | -10,00K | 0,00% |
Nettomutatie in liquide middelen | -6,75 mln. | -200,61% |
Vrije kasstroom | 900,88K | 99,64% |
Over
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Opgericht
1995
Hoofdvestiging
Website
Werknemers
53
